AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SULFATE DE MORPHINE

11 registrations across 1 African market— 11 active

Markets with SULFATE DE MORPHINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
MOSCONTIN
comprimé / 30 mg
🇸🇳SenegalSARGET PHARMAactive
VERMOR SR
comprimé / 10 mg
🇸🇳SenegalVERVEactive
VERMOR
ampoule injectable / 20 mg
🇸🇳SenegalVERVEactive
VERMOR
comprimé / 20 mg
🇸🇳SenegalVERVEactive
VERMOR SR
comprimé / 30 mg
🇸🇳SenegalVERVEactive
VERMOR
comprimé / 10 mg
🇸🇳SenegalVERVEactive
VERMOR
comprimé / 30 mg
🇸🇳SenegalVERVEactive
VERMOR SR
comprimé / 20 mg
🇸🇳SenegalVERVEactive
MOSCONTIN
comprimé / 60 mg
🇸🇳SenegalSARGET PHARMAactive
MOSCONTIN
comprimé / 10 mg
🇸🇳SenegalSARGET PHARMAactive
MOSCONTIN
comprimé / 100 mg
🇸🇳SenegalSARGET PHARMAactive

SULFATE DE MORPHINE in Africa — Regulatory Overview

SULFATE DE MORPHINE is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.